Prenatal exposure to organophosphates, paraoxonase 1, and cognitive development in childhood

Stephanie M Engel1, James Wetmur, Jia Chen

  • 1Department of Preventive Medicine, Mount Sinai School of Medicine, New York, New York, USA. Stephanie.Engel@unc.edu

Insights

Prenatal organophosphate pesticide exposure harms child cognitive development, especially perceptual reasoning. The enzyme Paraoxonase 1 (PON1) may influence susceptibility to these neurotoxic effects.

Area of Science:

  • Environmental Health
  • Neurodevelopmental Toxicology
  • Genetics

Background:

  • Prenatal organophosphate pesticide exposure is linked to adverse neurobehavioral outcomes in children.
  • Paraoxonase 1 (PON1) plays a crucial role in metabolizing organophosphates.

Purpose of the Study:

  • To investigate the association between organophosphate exposure biomarkers, PON1 status, and cognitive development in children.
  • To assess cognitive development at 12 and 24 months, and 6-9 years of age.

Main Methods:

  • The Mount Sinai Children's Environmental Health Study enrolled 404 mother-child pairs.
  • Organophosphate metabolites were measured in maternal urine, and PON1 activity/genotype in maternal blood.
  • Children underwent neurodevelopmental assessments at multiple ages.

Main Results:

  • Higher prenatal organophosphate metabolite levels correlated with lower mental development at 12 months in Black and Hispanic children.
  • These effects were more pronounced in children with the PON1 Q192R QR/RR genotype.
  • In later childhood, organophosphate exposure was linked to reduced perceptual reasoning in children of mothers with the QQ genotype (slow PON1 activity).

Conclusions:

  • Prenatal organophosphate exposure is negatively associated with cognitive development, particularly perceptual reasoning, from infancy through early childhood.
  • PON1 genotype may act as a significant susceptibility factor, modulating the impact of prenatal organophosphate exposure on child development.
Abstract

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is also...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Piaget's Stage 1 of Cognitive Development01:14

Piaget's Stage 1 of Cognitive Development

The sensorimotor stage, the initial phase of Jean Piaget's theory of cognitive development, spans the first two years of a child's life. During this period, infants actively engage with their surroundings, building cognitive awareness through direct interaction with the world. This interaction is primarily based on sensory perception and motor actions, allowing infants to gradually understand basic physical properties and predict how objects interact within their environment.
Exploration...